[CH:1]1[C:2]2[N:3]([C:7]([CH2:10][OH:11])=[CH:8][CH:9]=2)[CH:4]=[CH:5][N:6]=1>CCOC(C)=O>[CH:1]1[C:2]2[N:3]([C:7]([CH:10]=[O:11])=[CH:8][CH:9]=2)[CH:4]=[CH:5][N:6]=1Pyrrolo[1,2-a]pyrazin-6-yl-methanol (0.06 g, 0.41 mmol) is dissolved in EtOAc (3 mL), treated with IBX (0.34 g, 1.2 mmol) and heated to 80° C. for 3 h. The solution was allowed to cool to RT and filtered with a syringe filter frit. The solution was concentrated under a nitrogen stream to yield the title compound (0.06 g), which was used without further purification. 1H NMR (CDCl3) δ 9.87 (s, 1H), 9.34 (d, 1H), 9.02 (s, 1H), 7.93 (d, 1H), 7.47 (d, 1H), 6.82 (d, 1H).